Timing | Tumor characteristics | Nerve-sparing | Hormone therapy | |||||
---|---|---|---|---|---|---|---|---|
r p-value | Age at RP | Follow-up duration | Age at follow-up | PSA | T-stage | Gleason score | ||
UF | / | / | -0.609 0.024 | -3.557 0.163 | -3.103 0.163 | -2.878 0.072 | / | -5.607 0.056 |
UB | / | / | / | -2.944 0.207 | -4.161 0.051 | -2.272 0.125 | 2.774 0.046 | -3.718 0.189 |
SF | -1.304 0.617 | -0.229 0.302 | 0.176 0.946 | -1.104 0.601 | -4.264 0.024 | -2.106 0.110 | 3.783 0.004 | -4.259 0.044 |
SB | / | 0.290 <0.001 | 0.272 0.336 | / | -4.852 0.018 | / | 5.101 <0.001 | -7.205 0.076 |